Cardinal Health, Inc.

Hello and welcome to the fourth quarter fiscal year 2025 Cardinal Health Incorporated earnings conference call. My name is George. I'll be coordinator of today's event. Please note that this conference is being recorded and for the duration of the call, your lines have been listed only mode. However, you will have the opportunity to ask questions towards the end of the presentation, and this can be done by pressing star one on your keyboard to register your question. Can you also please limit yourselves to one question each to allow the maximum attendees to ask a question? If you are assistance at any point, please press star zero and you'll be connected to an operator. I'd like to call out your host today, Mr. Matt Sims, Vice President of Investor Relations, to be at today's conference. Please go ahead, sir.

Good morning, and welcome to Cardinal Health's fourth quarter fiscal 25 earnings conference calls. And thank you for joining us. With me today are Cardinal Health CEO, Jason Haller, and our CFO, Aaron Ault. You can find this morning's earnings press release and investor presentation on the investor relations section of our website at ir.cardinalhealth.com. Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a description of these risks and uncertainties. Please note that during our discussion today, the comments will be on a non-GAAP basis, unless specifically called out as GAAP. GAAP to non-GAAP reconciliations for all relevant periods can be found in the supporting schedules attached to our press release. For the Q&A portion of today's call, we kindly ask that you limit questions to one per participant so that we can try and give everyone an opportunity. With that, I will now turn the call over to Jason.

Thanks, Matt, and good morning, everyone. We closed fiscal 25 with momentum, delivering excellent fourth quarter results in what was a transformative year for Cardinal Health. Our consistent performance with all five operating segments delivering double-digit profit growth both the year and Q4 reflects the significant progress we've made against our strategic priorities. As we outlined in Investor Day, our strategy is clear and we continue to deliver on our commitments, reflecting disciplined execution across each of our operating segments. Our relentless focus on driving simplification and operational efficiencies in our core, along with strategic investments for growth, are enabling us to evolve to meet the needs of our customers and drive long-term value creation. Before I get into the specifics, and Aaron takes us through the financials, I want to recognize the hard work and dedication of our teams around the world. Their commitment to our mission and our customers is essential to strengthening our position as healthcare's most trusted partner at a time when reliability, resiliency, and access are more important than ever. Within pharmaceutical and specialty solutions, our largest and most significant business, we continue to see robust pharmaceutical demand and strong underlying performance. Our path forward remains well-defined and consistent. Prioritize the growth and resiliency of this business by building upon our strong core foundation and further expanding in specialty, as you saw in our press release this morning. We're thrilled to announce the acquisition of Solaris Health, the country's leading urology managed services organization. This greatly accelerates our progress in building the Specialty Alliance's multi-specialty MSO platform, significantly expanding the reach of our Urology Alliance physician network. We see substantial opportunity ahead with Cardinal Health positioned as the multi-specialty leader, and I'll elaborate on this shortly. In GMPD, our improvement plan initiatives are driving results, delivering $70 million in profit for the fourth quarter. The team continues to navigate the current environment to optimize our global footprint and increase supply chain resiliency for our customers. We see further opportunities ahead to continue to drive the GMPD improvement plan. Our differentiated growth businesses within other, made substantial contributions this quarter, capping off a year of meaningful momentum. The performance was broad-based, with strong growth across at-home solutions, now including the acquisition of ADS, nuclear and precision health solutions, and Opti-freight logistics. As we close out fiscal 25 and look ahead, we have great optimism in what we will achieve in fiscal 26. We continue to make strategic investments to optimize the business and position us for success. I'll dive deeper into these and other updates shortly, but we'll now turn it over to Aaron to take us through the financials.